|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.48 HKD | +6.05% |
|
+4.26% | -22.97% |
| 06-18 | Medtide Inc. Announces Abolishment of the Supervisory Committee | CI |
| 03-31 | Medtide Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Company Valuation: Medtide Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 3,884 | 2,886 | - | - |
| Change | - | -25.7% | - | - |
| Enterprise Value (EV) 1 | 3,027 | 1,988 | 1,805 | 1,622 |
| Change | - | -34.33% | -9.2% | -10.11% |
| P/E | - | - | - | - |
| PBR | 2.31x | 1.49x | 1.27x | 1.08x |
| PEG | - | - | - | - |
| Capitalization / Revenue | 6.81x | 4.22x | 3.3x | 2.7x |
| EV / Revenue | 5.31x | 2.91x | 2.06x | 1.52x |
| EV / EBITDA | 12.6x | 6.99x | 4.78x | 3.59x |
| EV / EBIT | 14.2x | 7.96x | 5.5x | 3.98x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | - | - | - |
| Distribution rate | - | - | - | - |
| Net sales 1 | 570.1 | 684.1 | 875.7 | 1,068 |
| EBITDA 1 | 240.2 | 284.6 | 377.7 | 452.1 |
| EBIT 1 | 212.4 | 249.7 | 328.4 | 408.1 |
| Net income | - | - | - | - |
| Net Debt 1 | -857.2 | -898.1 | -1,081 | -1,263 |
| Reference price 2 | 27.39 | 20.35 | 20.35 | 20.35 |
| Nbr of stocks (in thousands) | 141,800 | 141,800 | - | - |
| Announcement Date | 30/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 3.28x | 7.88x | -.--% | 400M | ||
| 32.21x | 5.68x | 17.59x | 1.02% | 46.2B | ||
| -22.9x | 343.72x | -21.86x | -.--% | 38.71B | ||
| 23.26x | 2.64x | 11.39x | -.--% | 31.9B | ||
| 41.76x | 4.18x | 26.75x | -.--% | 31.12B | ||
| 27.93x | 7.24x | 18.62x | 0.45% | 23.77B | ||
| 30.92x | 5x | 22.8x | -.--% | 15.05B | ||
| 23.95x | 2.04x | 8.96x | 1.12% | 13.74B | ||
| -22.52x | 14.77x | -22.09x | -.--% | 13.42B | ||
| Average | 16.83x | 43.17x | 7.78x | 0.29% | 23.81B | |
| Weighted average by Cap. | 17.76x | 66.52x | 8.30x | 0.34% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 3880 Stock
- Valuation Medtide Inc.
Select your edition
All financial news and data tailored to specific country editions
















